INSP vs. BMY
INSP (Inspire Medical Systems, Inc.) and BMY (Bristol-Myers Squibb Company) are both stocks. Both are in the Healthcare sector — INSP in Medical Devices, BMY in Drug Manufacturers - General. Over the past 5 years, INSP returned -26.94%/yr vs 0.49%/yr for BMY. At a 0.17 correlation, their price movements are largely independent.
Performance
INSP vs. BMY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, INSP achieves a -55.17% return, which is significantly lower than BMY's 3.67% return.
INSP
- 1D
- -2.96%
- 1M
- -5.68%
- YTD
- -55.17%
- 6M
- -57.78%
- 1Y
- -68.41%
- 3Y*
- -49.18%
- 5Y*
- -26.94%
- 10Y*
- —
BMY
- 1D
- 1.30%
- 1M
- -8.01%
- YTD
- 3.67%
- 6M
- 2.30%
- 1Y
- 22.56%
- 3Y*
- -1.14%
- 5Y*
- 0.49%
- 10Y*
- 0.91%
INSP vs. BMY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
INSP Inspire Medical Systems, Inc. | -55.17% | -50.25% | -8.87% | -19.24% | 9.48% | 22.31% | 153.46% | 75.64% | 72.52% |
BMY Bristol-Myers Squibb Company | 3.67% | 0.11% | 15.81% | -26.14% | 18.98% | 2.88% | 0.41% | 27.74% | 2.32% |
Correlation
The correlation between INSP and BMY is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.13 |
Correlation (All Time) Calculated using the full available price history since May 3, 2018 | 0.17 |
Fundamentals
INSP:
$1.19B
BMY:
$111.78B
INSP:
$4.48
BMY:
$3.57
INSP:
9.23
BMY:
15.34
INSP:
0.05
BMY:
0.88
INSP:
1.32
BMY:
2.30
INSP:
1.50
BMY:
5.57
INSP:
$915.25M
BMY:
$48.48B
INSP:
$785.06M
BMY:
$33.33B
INSP:
$67.14M
BMY:
$13.34B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
INSP vs. BMY — Risk / Return Rank
INSP
BMY
INSP vs. BMY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Inspire Medical Systems, Inc. (INSP) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| INSP | BMY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.76 | ||
| Sortino ratioReturn per unit of downside risk | -2.91 | ||
| Omega ratioGain probability vs. loss probability | 0.79 | 1.16 | -0.38 |
| Calmar ratioReturn relative to maximum drawdown | -0.95 | 1.81 | -2.76 |
| Martin ratioReturn relative to average drawdown | -1.45 | 4.13 | -5.58 |
Loading charts...
Drawdowns
INSP vs. BMY - Drawdown Comparison
The maximum INSP drawdown since its inception was -87.72%, which is greater than BMY's maximum drawdown of -72.03%. Use the drawdown chart below to compare losses from any high point for INSP and BMY.
Loading charts...
Drawdown Indicators
| INSP | BMY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -87.72% | -72.03% | -15.69% |
Max Drawdown (1Y)Largest decline over 1 year | -72.19% | -12.53% | -59.66% |
Max Drawdown (3Y)Largest decline over 3 years | -87.72% | -36.02% | -51.70% |
Max Drawdown (5Y)Largest decline over 5 years | -87.72% | -47.67% | -40.05% |
Max Drawdown (10Y)Largest decline over 10 years | — | -47.67% | — |
Current DrawdownCurrent decline from peak | -87.32% | -21.28% | -66.04% |
Average DrawdownAverage peak-to-trough decline | -27.91% | -22.38% | -5.53% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 47.31% | 5.48% | +41.83% |
Volatility
INSP vs. BMY - Volatility Comparison
Inspire Medical Systems, Inc. (INSP) has a higher volatility of 10.74% compared to Bristol-Myers Squibb Company (BMY) at 8.54%. This indicates that INSP's price experiences larger fluctuations and is considered to be riskier than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| INSP | BMY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.74% | 8.54% | +2.20% |
Volatility (6M)Calculated over the trailing 6-month period | 46.88% | 17.98% | +28.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 74.93% | 26.98% | +47.95% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 60.32% | 24.08% | +36.24% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 60.48% | 25.31% | +35.17% |
Dividends
INSP vs. BMY - Dividend Comparison
INSP has not paid dividends to shareholders, while BMY's dividend yield for the trailing twelve months is around 4.57%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 4.57% | 4.60% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% |
INSP Inspire Medical Systems, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
INSP vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Inspire Medical Systems, Inc. and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
INSP vs. BMY - Profitability Comparison
INSP - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Inspire Medical Systems, Inc. reported a gross profit of 176.91M and revenue of 204.58M. Therefore, the gross margin over that period was 86.5%.
BMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a gross profit of 8.07B and revenue of 11.49B. Therefore, the gross margin over that period was 70.2%.
INSP - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Inspire Medical Systems, Inc. reported an operating income of -1.12M and revenue of 204.58M, resulting in an operating margin of -0.6%.
BMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported an operating income of 3.27B and revenue of 11.49B, resulting in an operating margin of 28.5%.
INSP - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Inspire Medical Systems, Inc. reported a net income of -11.29M and revenue of 204.58M, resulting in a net margin of -5.5%.
BMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a net income of 2.68B and revenue of 11.49B, resulting in a net margin of 23.3%.
Frequently Asked Questions
INSP and BMY have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
INSP has higher volatility (10.74%) compared to BMY (8.54%). In terms of maximum drawdown, INSP dropped -87.72% vs BMY's -72.03%.
BMY currently has the higher Sharpe Ratio (0.84 vs -0.92), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for INSP and BMY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer